Online citations, reference lists, and bibliographies.
← Back to Search

Phagocytosis And Killing Of Cryptococcus Neoformans By Rat Alveolar Macrophages In The Absence Of Serum

B. Bolaños, T. Mitchell
Published 1989 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The in vitro interaction between yeast cells of Cryptococcus neoformans and Lewis rat alveolar macrophages (AMÕ) was studied in the absence of serum. AMÕ were harvested by lung lavage, and monolayers of adherent cells were established in wells of microtiter plates. Radiolabeled yeast cells were added to fresh AMÕ monolayers, the plates were incubated at 37°C under 5% CO2, nonadherent yeasts were removed, and phagocytosis (i.e., attachment or ingestion) was determined by measuring adherent radioactivity. AMÕ were able to bind or ingest, and kill, encapsulated strains of C. neoformans in the absence of serum. Serum‐free phagocytosis was suboptimal by comparison with phagocytosis in the presence of serum. The mechanism of serum‐free phagocytosis Involves a receptor on the AMÕ with affinity for mannose‐rich determinants present on the yeast cell walls and unrelated to the capsular polysaccharide. Opsonin‐independent phagocytosis was only detected with nonencapsulated, small, and medium encapsulated strains of C. neoformans. Large encapsulated strains were not taken up without serum. Serum‐free phagocytosis could be of critical importance in the alveolar spaces, where only marginal concentrations of serum opsonins are initially present.
This paper references
10.1128/IAI.5.4.491-498.1972
In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.
T. Mitchell (1972)
Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium.
D. Mosier (1981)
10.1080/02681218980000301
Killing of Cryptococcus neoformans by rat alveolar macrophages.
B. Bolaños (1989)
Analysis of proteins and respiratory cells obtained from human lungs by lung lavage
H. Y. Reynolds (1974)
10.1111/j.1439-0507.1987.tb04387.x
Untersuchungen zur elektronenmikroskopischen Darstellung der Kapsel von Cryptococcus neoformans. Ultrastructural Research on the Capsule of Cryptococcus neoformans
R. Weiß (1987)
10.1016/0006-291X(80)91139-0
A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activity.
G. Warr (1980)
Yeast mannans inhibited binding and phagocytosis of zymosan by mouse peritoneal macrophages
S-S. J. Sung (1983)
10.1093/INFDIS/125.4.412
Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition.
K. Powell (1972)
Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.
H. Reynolds (1974)
10.7326/0003-4819-94-5-611
The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors.
T. Kerkering (1981)
10.1128/IAI.54.3.735-741.1986
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.
J. Small (1986)
10.1016/S0006-291X(80)80237-3
Chloroquine and ammonium ion inhibit receptor-mediated endocytosis of mannose-glycoconjugates by macrophages: apparent inhibition of receptor recycling.
C. Tietze (1980)
10.1083/JCB.96.1.160
Yeast Mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages
SJ Sung (1983)
10.1128/IAI.43.3.879-886.1984
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
T. Kozel (1984)
Tissue changes and tissue diagnosis in cryptococcosis . A study of twenty - six cases
R. K. Haugen (1955)
10.1128/IAI.3.2.287-294.1971
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.
T. Kozel (1971)
10.1002/jlb.36.6.689
Opsonin‐Independent Phagocytosis of Surface‐Adherent Bacteria by Human Alveolar Macrophages
D. A. Lee (1984)
10.1378/CHEST.30.5.499
Pathogenesis of cardiac rupture due to myocardial infarction; a study of twenty-six cases.
J. Lunseth (1956)
Inflammatory and immune processes of the human lung in health and disease: evaluation by pulmonary layage
B. W. Hunninghale (1979)
Untersuchungen zur elek - tronenmikroskopischen Darstellung der Kapsel von Crvptococcus neoformans
R. Weiss
An evaluation of various environmental factors affecting the propagation of Crvpneoformans
Ishaq (1967)
10.1080/02681218980000291
Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
B. Bolaños (1989)
10.1083/JCB.96.1.1
Endocytosis and the recycling of plasma membrane
R. Steinman (1983)
10.1128/IAI.54.3.742-750.1986
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.
J. Small (1986)
10.1093/AJCP/25.1.14
Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases.
R. D. Baker (1955)
Micromorphology of Crvptococcus neoformans
M. R. Edwards (1967)
Inflammatory and immune processes of the human lung in health and disease : evaluation by pulmonary lay
B. W. Hunninghale (1979)



This paper is referenced by
10.1046/j.1440-1827.2000.01025.x
Quantitative analysis of apoptotic cell death in granulomatous inflammation induced by intravenous challenge with Cryptococcus neoformans and bacillus Calmette‐Guérin vaccine
K. Matsunaga (2000)
10.1080/02681219280000161
The interaction of Cryptococcus neoformans with primary rat lung cell cultures.
G. Merkel (1992)
10.1165/AJRCMB/5.1.19
Interferon-γ Activates Rat Alveolar Macrophages for Anticryptococcal Activity
C. Mody (1991)
10.1023/A:1006948825384
in Vitro Effect of Lung Surfactant on Alveolar Macrophage Defence Mechanisms Against Cryptococcus Neoformans
N. Gross (2004)
10.1016/j.fgb.2019.103261
Are Macrophages the Heroes or Villains During Cryptococcosis?
Jacob Rudman (2019)
10.1128/IAI.70.11.5972-5981.2002
Primary Dendritic Cells Phagocytose Cryptococcus neoformans via Mannose Receptors and Fcγ Receptor II for Presentation to T Lymphocytes
R. Syme (2002)
Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO 2
U. Banerjee (2003)
10.1172/JCI560
Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation.
H. Koziel (1998)
10.1099/mic.0.051524-0
Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin.
Jamal Stie (2012)
Mechanisms of brain infection by the human fungalpathogen Cryptococcus neoformans
Wilber Sabiiti (2012)
10.1128/IAI.00317-06
In Vivo Role of Dendritic Cells in a Murine Model of Pulmonary Cryptococcosis
K. Wozniak (2006)
10.4049/jimmunol.175.5.3244
An Innate Immune System Cell Is a Major Determinant of Species-Related Susceptibility Differences to Fungal Pneumonia1
Xiuping Shao (2005)
10.1016/J.ENVRES.2005.08.007
Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages.
M. Lundborg (2006)
10.3390/jof4010025
Mechanisms of Pulmonary Escape and Dissemination by Cryptococcus neoformans
Steven T. Denham (2018)
10.1371/journal.pone.0035455
Capsule Independent Uptake of the Fungal Pathogen Cryptococcus neoformans into Brain Microvascular Endothelial Cells
Wilber Sabiiti (2012)
10.1128/CMR.9.4.469
Virulence factors of medically important fungi.
L. H. Hogan (1996)
10.2217/fmb.12.102
Mechanisms of infection by the human fungal pathogen Cryptococcus neoformans.
Wilber Sabiiti (2012)
10.1128/IAI.71.11.6155-6164.2003
Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO2
Oscar Zaragoza (2003)
10.1046/j.1365-3083.2000.00755.x
A Soluble Mannose Receptor Immunoadhesin Enhances Phagocytosis of Pneumocystis carinii by Human Polymorphonuclear Leukocytes In Vitro
Stehle (2000)
10.1016/B978-012775390-4/50222-0
Experimental Pulmonary Cryptococcus neoformans Infection in Rats
D. Goldman (1999)
10.1128/IAI.62.11.4755-4761.1994
Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.
D. Goldman (1994)
10.1080/02681219280000381
Granulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice.
K. Uchida (1992)
10.1080/02681219780001371
Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
R. K. Li (1997)
10.1128/CMR.8.4.515
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
T. Mitchell (1995)
10.1084/jem.20082109
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36
T. Means (2009)
10.3389/fimmu.2020.581750
Animal Models of Cryptococcus neoformans in Identifying Immune Parameters Associated With Primary Infection and Reactivation of Latent Infection
Tyler G Normile (2020)
10.1093/INFDIS/166.4.866
Binding of unopsonized Cryptococcus neoformans by human bronchoalveolar macrophages: inhibition by a large-molecular-size serum component.
S. Levitz (1992)
10.1152/JAPPLPHYSIOL.01067.2001
Experimental and calculated parameters on particle phagocytosis by alveolar macrophages.
P. Camner (2002)
10.1016/S1874-5172(99)80029-7
Mannose receptor and phagocytosis
I. Fraser (1999)
10.1074/jbc.M110.177030
Glucuronoxylomannan from Cryptococcus neoformans Down-regulates the Enzyme 6-Phosphofructo-1-kinase of Macrophages*
J. Grechi (2011)
10.1007/s00018-015-1858-6
Mononuclear phagocyte-mediated antifungal immunity: the role of chemotactic receptors and ligands
Muthulekha Swamydas (2015)
10.1080/02681219380000061
Conditions affecting the adherence of Cryptococcus neoformans to rat glial and lung cells in vitro.
G. Merkel (1993)
See more
Semantic Scholar Logo Some data provided by SemanticScholar